Skip to content
ClinCalc Pro
Menu
Lubricant Pregnancy: UK SPC §4.6: 'As with all medicines, avoid during early pregnancy and during lactation.'

Liquid paraffin

Liquid paraffin is a mineral-oil lubricant laxative used for the short-term relief of constipation; it is also used as a lubricant in some ophthalmic and skin preparations.

Adult dose

Dose: Temporary relief of constipation — Liquid Paraffin B.P. (100.0% v/v), oral: adults, the elderly and children over 12 years, two to six 5 ml spoonfuls (i.e. 10 to 30 ml) taken at bedtime.
Route: Oral
Frequency: At bedtime
VERBATIM UK SPC §4.2 (LIQUID PARAFFIN B.P., PL183740044): 'Adults, the elderly and children over 12 years Two to six 5 ml spoonfuls (i.e. 10 to 30 ml) to be taken at bedtime.' §4.1: 'For the temporary relief of constipation.' §2: 'Liquid Paraffin 100.0% v/v'. The SPC prints no maximum dose beyond that range, so none is given. SCOPE: this covers the ORAL route only; the page also names topical and ophthalmic uses, which this SPC does not cover (the earlier-fetched Doublebase bath additive is a different, external-use combination product and was not used). SPC §4.4: 'Avoid prolonged use. Consult your doctor if laxatives are needed every day, if you have persistent abdominal pain or have a condition which makes swallowing difficult.' §4.3: not for use 'in patients with undiagnosed abdominal symptoms'.

Paediatric dose

Dose: Constipation: children 5 to 12 years, one to two 5 ml spoonfuls (i.e. 5 to 10 ml) at bedtime; children 3 to 5 years, one half to one 5 ml spoonful (i.e. 2.5 to 5 ml) at bedtime; children under 3 years, not recommended
Route: Oral
Frequency: At bedtime
As printed in UK SPC §4.2: 'Children 5 to 12 years One to two 5 ml spoonfuls (i.e. 5 to 10 ml) to be taken at bedtime. Children 3 to 5 years One half to one 5 ml spoonful (i.e. 2.5 to 5 ml) to be taken at bedtime. Children under 3 years Not recommended.' §4.3 lists children under 3 years as a contraindication. The SPC gives no neonatal figure and none is implied. Verify any under-18 dose against a children's formulary before use.

Dose adjustments

Renal

Not stated — the SPC contains no renal-impairment statement.

Hepatic

Not stated — the SPC contains no hepatic-impairment statement.

Dose independently re-sourced from UK Summary of Product Characteristics (SPC) via MHRA Products — clinician-reviewed. Always confirm against the product SmPC and your local formulary before prescribing.

Contraindications

  • Children under 3 years (§4.3)
  • Patients with undiagnosed abdominal symptoms, as for other laxatives (§4.3)

Side effects

  • Anal seepage of paraffin and consequent anal irritation after prolonged use (§4.8)
  • Granulomatous reactions caused by absorption of liquid paraffin (§4.8)
  • Lipoid pneumonia (by accidental inhalation) — caution is required in patients with swallowing difficulties (§4.8)

Interactions

  • There may be interference with the absorption of fat soluble vitamins (§4.5)

Clinical monograph

How it works

Taken orally it lubricates and softens the faecal mass by coating the stool and bowel wall, easing passage.

Prescribing in practice

  • Aspiration of liquid paraffin can cause lipoid pneumonia, so avoid use in those at risk of aspiration and do not take immediately before lying down.
  • Prolonged use may impair absorption of fat-soluble vitamins and cause anal seepage with irritation, so it is intended only for short-term use.
  • It is not recommended in young children because of the aspiration risk; reserve oral use for short-term relief in suitable patients.

Monitoring

Routine laboratory monitoring is not required for short-term use; review the response and avoid prolonged or repeated courses.

Counselling the patient

  • Use this only for short-term relief and do not take it just before going to bed or lying down.
  • See your clinician if constipation persists rather than continuing it long term.

Evidence & guidelines

Liquid paraffin is a recognised laxative whose use is limited by aspiration and absorption concerns, consistent with cautions in current prescribing references.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.